v3.26.3
Condensed Consolidated Interim Statements of Stockholder' Deficit - USD ($)
Convertible Preferred Stock [Member]
Preferred Stock [Member]
Convertible Preferred Stock [Member]
Preferred Stock [Member]
Previously Reported [Member]
Convertible Preferred Stock [Member]
Preferred Stock [Member]
Change in Reporting Entity, Adjustment [Member]
Common Stock [Member]
Common Stock [Member]
Previously Reported [Member]
Common Stock [Member]
Change in Reporting Entity, Adjustment [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Previously Reported [Member]
Additional Paid-in Capital [Member]
Change in Reporting Entity, Adjustment [Member]
Treasury Stock, Common [Member]
Treasury Stock, Common [Member]
Previously Reported [Member]
Treasury Stock, Common [Member]
Change in Reporting Entity, Adjustment [Member]
Share Subscription Receivable [Member]
Share Subscription Receivable [Member]
Previously Reported [Member]
Share Subscription Receivable [Member]
Change in Reporting Entity, Adjustment [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Previously Reported [Member]
Retained Earnings [Member]
Change in Reporting Entity, Adjustment [Member]
AOCI Attributable to Parent [Member]
AOCI Attributable to Parent [Member]
Previously Reported [Member]
AOCI Attributable to Parent [Member]
Change in Reporting Entity, Adjustment [Member]
Total
Previously Reported [Member]
Change in Reporting Entity, Adjustment [Member]
Balance at Dec. 31, 2023 $ 7,865,000 $ 7,865,000 $ 1,000 $ 2,000 $ (1,000) $ 2,308,000 $ 2,307,000 $ (1,000) $ (18,834,000) $ (18,834,000) $ 193,000 $ 193,000 $ (8,467,000) $ (8,467,000)
Balance, shares at Dec. 31, 2023 5,950,673 9,043,234 (3,092,561) 6,067,341 9,220,534 (3,153,193)                                    
Balance, shares at Dec. 31, 2023 [1],[2]                                            
Stock-based compensation         1,067,000                     1,067,000    
Net loss                       (15,383,000)         (15,383,000)    
Issuance of shares upon repayment of 2023 Promissory Notes         899,000                     899,000    
Issuance of shares upon repayment and forgiveness of 2023 Promissory Notes, shares       1,618,549                                        
Foreign currency translation                         57,000     57,000    
Common stock repurchase             (2,903,000)                 2,903,000    
Common stock repurchase, shares       (438,903)           438,903 [1],[2]                            
Issuance of common stock upon exercise of stock option         12,000                     12,000    
Issuance of common stock upon exercise of stock option, shares       17,205                                        
Gain on extinguishment recorded as a capital transaction         343,000                     343,000    
Deemed dividend related to Shortfall Warrants modification ( refer note 15 )         70,000                     70,000    
Net loss                                           (15,383,000)    
Balance at Dec. 31, 2024 $ 7,865,000 $ 7,865,000 $ 1,000 $ 2,000 $ (1,000) 4,699,000 4,698,000 1,000 $ (2,903,000) [3],[4] $ (2,903,000) [3],[4] [3],[4] (34,217,000) (34,217,000) 250,000 250,000 $ (24,305,000) (24,305,000)
Balance, shares at Dec. 31, 2024 [3],[4] 5,950,673 9,043,234 (3,092,561) 7,264,192 11,039,388 (3,775,196)                                    
Balance, shares at Dec. 31, 2024                   438,903 [1],[2],[3],[4] 667,000 [3],[4] (228,097) [3],[4]                   438,903    
Stock-based compensation         118,000     [3],[4]                 $ 118,000    
Loss for extinguishment of convertible notes payable         391,000     [3],[4]                 391,000    
Net loss             [3],[4]         (4,039,000)         (4,039,000)    
Issuance of shares upon repayment of 2023 Promissory Notes         3,000     [3],[4]                 3,000    
Issuance of shares upon repayment of 2023 Promissory Notes, shares [3],[4]       6,772                                        
Balance at Jun. 30, 2025 $ 7,865,000 [3],[4]     $ 1,000 [3],[4]     5,211,000     $ (2,903,000) [3],[4]         (38,256,000)     250,000     (27,832,000)    
Balance, shares at Jun. 30, 2025 [3],[4] 5,950,673     7,270,964                                        
Balance, shares at Jun. 30, 2025 [3],[4]                   438,903                            
Balance at Dec. 31, 2024 $ 7,865,000 $ 7,865,000 $ 1,000 $ 2,000 $ (1,000) 4,699,000 $ 4,698,000 $ 1,000 $ (2,903,000) [3],[4] $ (2,903,000) [3],[4] [3],[4] (34,217,000) $ (34,217,000) 250,000 $ 250,000 $ (24,305,000) $ (24,305,000)
Balance, shares at Dec. 31, 2024 [3],[4] 5,950,673 9,043,234 (3,092,561) 7,264,192 11,039,388 (3,775,196)                                    
Balance, shares at Dec. 31, 2024                   438,903 [1],[2],[3],[4] 667,000 [3],[4] (228,097) [3],[4]                   438,903    
Stock-based compensation         231,000                     $ 231,000    
Net loss                       (928,000)         (928,000)    
Issuance of shares upon repayment of 2023 Promissory Notes         3,000                       3,000    
Issuance of shares upon repayment and forgiveness of 2023 Promissory Notes, shares       6,772                                        
Issuance of common stock upon cashless exercise of stock option         707,000                             707,000    
Issuance of common stock upon cashless exercise of stock option, shares       745,896                                        
Shares withheld related to cashless exercise         707,000                             707,000    
Shares withheld related to cashless exercise, shares       (79,234)                                        
Issuance of common stock upon the reverse recapitalization, net of issuance costs (refer note 20)       $ 1,000     8,507,000                           8,508,000    
Issuance of common stock upon the reverse recapitalization, net of issuance costs (refer note 20), shares       12,456,071                                        
Issuance of shares as a result of Conversion of convertible notes           10,157,000                             10,157,000    
Issuance of shares as a result of Conversion of convertible notes, shares       1,976,050                                        
Shares issued to a vendor of Legacy Fusemachines to settle outstanding invoices.           198,000                             198,000    
Shares issued to a vendor of Legacy Fusemachines to settle outstanding invoices., shares       29,611                                        
Transfer of Fusemachines Inc. common stock to a third party vendor           151,000                             151,000    
CSLM Sponsor Transfer of Pubco Shares to Fusemachines third party, shares                                              
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization $ (7,865,000)     $ 1,000     7,864,000                                
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization, shares (5,950,673)     5,950,673                                        
Treasury stock cancellation upon reverse recapitalization             (2,903,000)     $ 2,903,000                          
Treasury stock cancellation upon reverse recapitalization, shares [1],[2]                   (438,903)                            
Prepaid forward purchase agreement                         11,005,000                 11,005,000    
Issuance of shares pursuant to PIPE transaction (refer note 23)           1,000,000                             1,000,000    
Issuance of shares pursuant to PIPE transaction (refer note 23), shares       588,235                                        
Issuance of warrants related to forward purchase agreement and convertible note agreement (refer note 10 &22 )             1,013,000                             1,013,000    
Loss for extinguishment of convertible notes payable         391,000                     391,000    
Foreign currency translation                         10,000     $ 10,000    
Issuance of common stock upon exercise of stock option, shares                                           6,772    
Net loss                                           $ (928,000)    
Balance at Dec. 31, 2025     $ 3,000     31,311,000     [3],[4]     (11,005,000)     (35,145,000)     260,000     $ (14,576,000)    
Balance, shares at Dec. 31, 2025 [3],[4]     28,938,266                                        
Balance, shares at Dec. 31, 2025                   [1],[2],[3],[4]                          
Balance at Mar. 31, 2025 $ 7,865,000 [3],[4]     $ 1,000 [3],[4]     5,158,000     $ (2,903,000) [3],[4]         (34,470,000)     250,000     $ (24,099,000)    
Balance, shares at Mar. 31, 2025 [3],[4] 5,950,673     7,270,964                                        
Balance, shares at Mar. 31, 2025 [3],[4]                   438,903                            
Stock-based compensation [3],[4]     [3],[4]     53,000     [3],[4]                 53,000    
Net loss [3],[4]     [3],[4]           [3],[4]         (3,786,000)           (3,786,000)    
Balance at Jun. 30, 2025 $ 7,865,000 [3],[4]     $ 1,000 [3],[4]     5,211,000     $ (2,903,000) [3],[4]         (38,256,000)     250,000     (27,832,000)    
Balance, shares at Jun. 30, 2025 [3],[4] 5,950,673     7,270,964                                        
Balance, shares at Jun. 30, 2025 [3],[4]                   438,903                            
Balance at Dec. 31, 2025     $ 3,000     31,311,000     [3],[4]     (11,005,000)     (35,145,000)     260,000     $ (14,576,000)    
Balance, shares at Dec. 31, 2025 [3],[4]     28,938,266                                        
Balance, shares at Dec. 31, 2025                   [1],[2],[3],[4]                          
Stock-based compensation         878,000     [3],[4]                 $ 878,000    
Issuance of common stock upon cashless exercise of stock option         39,000     [3],[4]                 39,000    
Issuance of common stock upon cashless exercise of stock option, shares [3],[4]       21,456                                        
Shares withheld related to cashless exercise         (1,000)     [3],[4]                 (1,000)    
Shares withheld related to cashless exercise, shares [3],[4]       (741)                                        
Foreign currency translation             [3],[4]             9,000     9,000    
Issuance of common stock upon exercise of stock option         18,000     [3],[4]                 $ 18,000    
Issuance of common stock upon exercise of stock option, shares       26,321 [3],[4]                                   26,321    
Deemed dividend related to Shortfall Warrants modification ( refer note 15 )         84,000     [3],[4]         (84,000)            
Net loss             [3],[4]         (3,721,000)         (3,721,000)    
Balance at Jun. 30, 2026 [3],[4]     $ 3,000 [3],[4]     32,329,000     [3],[4]     (11,005,000)     (38,950,000)     269,000     (17,354,000)    
Balance, shares at Jun. 30, 2026 [3],[4]     28,985,302                                        
Balance, shares at Jun. 30, 2026 [3],[4]                                              
Balance at Mar. 31, 2026 [3],[4]     $ 3,000 [3],[4]     31,801,000     [3],[4]     (11,005,000)     (36,101,000)     269,000     (15,033,000)    
Balance, shares at Mar. 31, 2026 [3],[4]     28,939,240                                        
Balance, shares at Mar. 31, 2026 [3],[4]                                              
Stock-based compensation [3],[4]     [3],[4]     472,000     [3],[4]                 472,000    
Issuance of common stock upon cashless exercise of stock option [3],[4]     [3],[4]     38,000     [3],[4]                 38,000    
Issuance of common stock upon cashless exercise of stock option, shares [3],[4]       19,741                                        
Foreign currency translation [3],[4]     [3],[4]         [3],[4]                    
Issuance of common stock upon exercise of stock option [3],[4]     [3],[4]     18,000     [3],[4]                 18,000    
Issuance of common stock upon exercise of stock option, shares [3],[4]       26,321                                        
Net loss [3],[4]     [3],[4]         [3],[4]         (2,849,000)         (2,849,000)    
Balance at Jun. 30, 2026 [3],[4]     $ 3,000 [3],[4]     $ 32,329,000     [3],[4]     $ (11,005,000)     $ (38,950,000)     $ 269,000     $ (17,354,000)    
Balance, shares at Jun. 30, 2026 [3],[4]     28,985,302                                        
Balance, shares at Jun. 30, 2026 [3],[4]                                              
[1] In connection with the consummation of the business combination, the Company adopted a new capital structure and amended the par value of its common stock from $0.00001 per share to $0.0001 per share. Accordingly, the historical equity presentation has been adjusted to reflect the revised par value of the Company’s common stock. The change resulted in a reclassification of amounts within stockholders’ equity from additional paid-in capital to common stock to reflect the increased par value per share. This reclassification had no impact on total stockholders’ equity.
[2] The number of shares of convertible preferred stock and common stock issued and outstanding prior to the Merger have been retroactively adjusted by the Exchange Ratio to give effect to the reverse recapitalization treatment of the Merger.
[3] In connection with the consummation of the business combination, the Company adopted a new capital structure and amended the par value of its common stock from $0.00001 per share to $0.0001 per share. Accordingly, the historical equity presentation has been adjusted to reflect the revised par value of the Company’s common stock. The change resulted in a reclassification of amounts within stockholders’ deficit from additional paid-in capital to common stock to reflect the increased par value per share. This reclassification had no impact on total stockholders’ deficit.
[4] The number of shares of convertible preferred stock, common stock and treasury stock issued and outstanding prior to the Merger have been retroactively adjusted by the Exchange Ratio to give effect to the reverse recapitalization treatment of the Merger.